Dr. Scott Borinstein, M.D.
Claim this profileVanderbilt University/Ingram Cancer Center
Expert in Rhabdomyosarcoma
Expert in Osteosarcoma
30 reported clinical trials
52 drugs studied
Area of expertise
1Rhabdomyosarcoma
Global LeaderStage IV
FOXO1 fusion negative
FOXO1 fusion positive
2Osteosarcoma
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Scott Borinstein, M.D. is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Chemotherapy
for Rhabdomyosarcoma
This trial is testing four different chemotherapy schedules for patients with a specific type of advanced cancer. The goal is to find the best way to treat the disease by comparing different timing and combinations of chemotherapy treatments.
Recruiting1 award Phase 2
More about Scott Borinstein, M.D.
Clinical Trial Related7 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Scott Borinstein, M.D. has experience with
- Cyclophosphamide
- Vincristine
- Cisplatin
- Dactinomycin
- Vinorelbine
- Carboplatin
Breakdown of trials Scott Borinstein, M.D. has run
Rhabdomyosarcoma
Osteosarcoma
Tumors
Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Borinstein, M.D. specialize in?
Scott Borinstein, M.D. focuses on Rhabdomyosarcoma and Osteosarcoma. In particular, much of their work with Rhabdomyosarcoma has involved Stage IV patients, or patients who are FOXO1 fusion negative.
Is Scott Borinstein, M.D. currently recruiting for clinical trials?
Yes, Scott Borinstein, M.D. is currently recruiting for 8 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Scott Borinstein, M.D. has studied deeply?
Yes, Scott Borinstein, M.D. has studied treatments such as Cyclophosphamide, Vincristine, Cisplatin.
What is the best way to schedule an appointment with Scott Borinstein, M.D.?
Apply for one of the trials that Scott Borinstein, M.D. is conducting.
What is the office address of Scott Borinstein, M.D.?
The office of Scott Borinstein, M.D. is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.